Wyss Institute
December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner
Thrive Global | November 12, 2018
This Sunday was Veterans Day, a time to honor those who have selflessly served our country. While our veterans are front and center on this day, they have been missing from a critical conversation over the past couple of years. By Kevin Hrusovsky
Multiple Sclerosis News Today | October 12, 2018
By Jose Marques Lopez, PhD
Washington Report | September 04, 2018
By: Kevin Hrusovsky
ALZFORUM.ORG | August 24, 2018
A lot can happen in a year.
Specialty Pharmacy Times | August 17, 2018
A new technology allows researchers to use brain biomarker neurofilament light chain (NfL) to uncover insights into the development and progression of neurological diseases, such as multiple sclerosis (MS).  
Genetic Engineering & Biotechnology News | January 15, 2018
New technology has shown promise for detecting CTE and the approximately 150 protein biomarkers linked to conditions in neurology, oncology, cardiology, inflammation, and infectious disease. Called Simoa™, it is a single-molecule array on a fully automated digital immunoassay platform that detects…
Alzforum | November 17, 2017
Serum NfL levels rise before symptoms appear in familial AD. NfL correlates with cognitive decline and brain atrophy. In MS patients, NfL levels drop with treatment.